0001638599-17-000126.txt : 20170130 0001638599-17-000126.hdr.sgml : 20170130 20170130213959 ACCESSION NUMBER: 0001638599-17-000126 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170126 FILED AS OF DATE: 20170130 DATE AS OF CHANGE: 20170130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lipocine Inc. CENTRAL INDEX KEY: 0001535955 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990370688 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 ARAPEEN DRIVE, SUITE 202 CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 BUSINESS PHONE: 801 994 7383 MAIL ADDRESS: STREET 1: 675 ARAPEEN DRIVE, SUITE 202 CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 FORMER COMPANY: FORMER CONFORMED NAME: MARATHON BAR CORP DATE OF NAME CHANGE: 20111130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ono Richard Dana CENTRAL INDEX KEY: 0001595989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36357 FILM NUMBER: 17559244 MAIL ADDRESS: STREET 1: 18 SPRING ROAD CITY: CONCORD STATE: MA ZIP: 01742 4 1 doc4_4501.xml PRIMARY DOCUMENT X0306 4 2017-01-26 0 0001535955 Lipocine Inc. LPCN 0001595989 Ono Richard Dana C/O 675 ARAPEEN DRIVE SUITE 202 SALT LAKE CITY UT 84108 1 0 0 0 Restricted Stock Unit 0 2017-01-26 4 A 0 7000 0 A 2017-12-31 2027-01-25 Common stock 7000 7000 D Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021. /s/Richard Dana Ono 2017-01-30